Sign in
HURA Stock Price, Chart, Stats & News
TuHURA Biosciences, Inc.
Save
141.69M
Market cap
–
Current P/E
–
Forward P/E
HURA chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -113.97% |
ROE | -193.06% |
D/E | 0.03x |
Interest coverage ratio | -54.36x |
HURA valuation
P/E | – |
P/S | – |
P/B | 5.47x |
P/CF | -3.12x |
P/FCF | -3.46x |
P/OCF | -3.12x |
PEG | -0.04x |
EV multiple | -3.64x |
About
TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies designed to effectively combat the mechanisms by which cancers develop resistance to existing immunotherapy treatments. Its operations are based in Tampa, Florida.
Similar securities
Based on sector and market capitalization
Report issue